These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21413052)

  • 1. Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis.
    Hov JR; Kosmoliaptsis V; Traherne JA; Olsson M; Boberg KM; Bergquist A; Schrumpf E; Bradley JA; Taylor CJ; Lie BA; Trowsdale J; Karlsen TH
    Hepatology; 2011 Jun; 53(6):1967-76. PubMed ID: 21413052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatic modifications of the human leukocyte antigen DR P9 peptide-binding pocket in primary sclerosing cholangitis: back to the future with human leukocyte antigen DRβ.
    Donaldson PT
    Hepatology; 2011 Jun; 53(6):1798-800. PubMed ID: 21538433
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis.
    Donaldson PT; Norris S
    Autoimmunity; 2002 Dec; 35(8):555-64. PubMed ID: 12765483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.
    Hov JR; Lleo A; Selmi C; Woldseth B; Fabris L; Strazzabosco M; Karlsen TH; Invernizzi P
    J Hepatol; 2010 May; 52(5):712-7. PubMed ID: 20347497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
    Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
    Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amino acid variation within the binding pocket 7 and 9 of HLA-DRB1 molecules are associated with primary Sjögren's syndrome.
    Huang R; Yin J; Chen Y; Deng F; Chen J; Gao X; Liu Z; Yu X; Zheng J
    J Autoimmun; 2015 Feb; 57():53-9. PubMed ID: 25582848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
    J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
    Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
    Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.
    Spurkland A; Saarinen S; Boberg KM; Mitchell S; Broome U; Caballeria L; Ciusani E; Chapman R; Ercilla G; Fausa O; Knutsen I; Pares A; Rosina F; Olerup O; Thorsby E; Schrumpf E
    Tissue Antigens; 1999 May; 53(5):459-69. PubMed ID: 10372541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population.
    Neri TM; Cavestro GM; Seghini P; Zanelli PF; Zanetti A; Savi M; Podda M; Zuin M; Colombo M; Floreani A; Rosina F; Bianchi Porro G; Strazzabosco M; Okolicsanyi L
    Dig Liver Dis; 2003 Aug; 35(8):571-6. PubMed ID: 14567462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
    Alexander J; Lord JD; Yeh MM; Cuevas C; Bakthavatsalam R; Kowdley KV
    Liver Transpl; 2008 Feb; 14(2):245-51. PubMed ID: 18236405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis.
    Moloney MM; Thomson LJ; Strettell MJ; Williams R; Donaldson PT
    Hepatology; 1998 Sep; 28(3):660-2. PubMed ID: 9731555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
    Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis.
    Foley PJ; McGrath DS; Puscinska E; Petrek M; Kolek V; Drabek J; Lympany PA; Pantelidis P; Welsh KI; Zielinski J; du Bois RM
    Am J Respir Cell Mol Biol; 2001 Sep; 25(3):272-7. PubMed ID: 11588003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis.
    Menconi F; Osman R; Monti MC; Greenberg DA; Concepcion ES; Tomer Y
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16899-903. PubMed ID: 20837527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.
    Fosby B; Næss S; Hov JR; Traherne J; Boberg KM; Trowsdale J; Foss A; Line PD; Franke A; Melum E; Scott H; Karlsen TH
    World J Gastroenterol; 2014 Apr; 20(14):3986-4000. PubMed ID: 24744588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosis.
    Junge N; Tiedau M; Verboom M; Hallensleben M; Blasczyk R; Schlue J; Goldschmidt I; Pfister ED; Baumann U
    Eur J Pediatr; 2016 Apr; 175(4):527-37. PubMed ID: 26567543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.
    Næss S; Lie BA; Melum E; Olsson M; Hov JR; Croucher PJ; Hampe J; Thorsby E; Bergquist A; Traherne JA; Schrumpf E; Boberg KM; Schreiber S; Franke A; Karlsen TH
    PLoS One; 2014; 9(12):e114486. PubMed ID: 25521205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of HLA class II alleles/haplotypes and amino acid variations in the peptide binding pockets with rheumatoid arthritis.
    Chinniah R; Rajendran MS; Sivanadham R; Adaikalam ML; Ravi PM; Vijayan M; Boopathy S; Pandi S; Sevak V; Karuppiah B
    Int J Rheum Dis; 2019 Aug; 22(8):1553-1562. PubMed ID: 31169355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution HLA-DRB1 analysis and shared molecular amino acid signature of DRβ1 molecules in Occult hepatitis B infection.
    Wang T; Shen C; Li H; Chen L; Liu S; Qi J
    BMC Immunol; 2022 Apr; 23(1):22. PubMed ID: 35468727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.